|
Delayed
Nasdaq Stockholm
11:44:16 29/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 8.660 SEK | -0.23% |
|
-2.59% | -35.85% |
| 09-24 | Vivesto to present Paccal Vet data at conference | FW |
| 09-24 | Vivesto AB Presents Paccal Vet Data At The Veterinary Cancer Society Annual Conference 2026 | CI |
| Market Cap | 96.1M 9.65M 8.49M 8.03M 7.28M 13.67M 926M 13.75M 37.11M 473M 36.23M 35.45M 1.52B | P/E 2026 * |
-2.88x | P/E 2027 * | -2.4x |
|---|---|---|---|---|---|
| Enterprise Value | 88.1M 8.85M 7.78M 7.36M 6.67M 12.53M 849M 12.61M 34.02M 433M 33.22M 32.5M 1.39B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
52.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| VIVE | Delayed | |
Deutsche Boerse AG
| OMA | Delayed | |
|
CBOE
| 0N4A | Real-time | |
|
CBOE
| OASMs | Real-time | |
|
Börse Stuttgart
| OMA | Delayed |
Last Transcript: Vivesto AB
| 1 week | -2.36% | ||
| Current month | -1.81% | ||
| 1 month | -1.81% | ||
| 3 months | +2.00% | ||
| 6 months | +11.86% | ||
| Current year | -35.70% |
| 1 week | 8.33 |  | 9.11 |
| 1 month | 8.33 | | 10 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 27.3 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 302.9 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 23/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 01/07/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 25/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 26/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 25/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/25/22 A | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 3/24/22 A | Others | Chairman | 120,000 | 0.0268% | ||
| 12/20/21 A | Free | Chief Executive Officer | 2,250,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -2.36% | -62.26% | -63.14% | 9.65M | |
| +0.11% | +1.71% | +63.52% | +117.61% | 1,056B | |
| +0.27% | +0.92% | +51.33% | +73.35% | 655B | |
| +0.73% | +0.68% | +20.70% | +74.90% | 471B | |
| -0.41% | -2.50% | +38.62% | +41.74% | 342B | |
| +0.37% | +4.71% | +23.11% | +29.90% | 277B | |
| +1.91% | +0.55% | +14.92% | +14.77% | 257B | |
| +0.85% | +6.35% | +53.17% | +54.39% | 226B | |
| +0.85% | +1.10% | +35.78% | +101.82% | 189B | |
| 0.00% | -2.30% | -28.07% | -60.73% | 170B | |
| Average | +0.38% | +0.50% | +21.08% | +38.46% | 364.29B | |
| Weighted average by Cap. | +0.14% | +1.04% | +40.61% | +70.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -31M -3.11M -2.74M -2.59M -2.35M -4.41M -299M -4.44M -11.97M -152M -11.69M -11.43M -490M | -40M -4.02M -3.53M -3.34M -3.03M -5.69M -386M -5.72M -15.45M -197M -15.08M -14.75M -632M |
| Net Debt | -8M -803K -707K -668K -606K -1.14M -77.12M -1.14M -3.09M -39.35M -3.02M -2.95M -126M | -17M -1.71M -1.5M -1.42M -1.29M -2.42M -164M -2.43M -6.57M -83.62M -6.41M -6.27M -269M |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/09/26 | SEK 8.660 | -0.23% | 1,398 |
| 28/09/26 | SEK 8.680 | -3.66% | 10,218 |
| 25/09/26 | SEK 9.010 | +2.50% | 2,826 |
| 24/09/26 | SEK 8.790 | -0.45% | 12,295 |
| 23/09/26 | SEK 8.830 | -0.67% | 5,449 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Select your edition
All financial news and data tailored to specific country editions
